by Raynovich Rod | Apr 24, 2015 | Biopharmaceuticals
Can Biotech Leadership Continue Up 20% YTD Biotech stocks were roughed up on Friday with a potential market rotation out of healthcare into technology. The XLK Technology SPDR was up 4% for the week compared to only 2% for the IBB. The XLK holds large cap stocks such...